<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01744314</url>
  </required_header>
  <id_info>
    <org_study_id>102903</org_study_id>
    <nct_id>NCT01744314</nct_id>
  </id_info>
  <brief_title>Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow Trauma</brief_title>
  <official_title>Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow Trauma: A Randomized Prospective Double-blinded Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients who present to our institution with a traumatic injury to their elbow who need
      operative management will be randomized to one of two groups; a treatment arm and a control
      arm. The treatment arm will receive a three-week postoperative course of indomethacin while
      the control group will not. We will follow both groups to assess whether or not indomethacin
      prophylaxis affects the rate of heterotopic ossification.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in post operative radiographic evaluation</measure>
    <time_frame>6 weeks and 3, 6 and 12 mfup</time_frame>
    <description>AS a standard care patients will be routinely assess at three, six , twelve and twenty four months post-operatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in range of motion</measure>
    <time_frame>6 weeks and 3, 6 and 12 mfup</time_frame>
    <description>measuring range of motion with a goniometer will be performed at 6 weeks and 3, 6 and 12 mfup</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Rate Elbow Evaluation</measure>
    <time_frame>6 weeks and 3, 6 and 12 mfup</time_frame>
    <description>is a 20-item questionnaire designed to measure elbow pain and disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Mayo Elbow Performance score</measure>
    <time_frame>6 weeks and 3, 6 and 12 mfup</time_frame>
    <description>is an instrument used to test the limitations to use the elbow during ADL caused by the pathology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disabilities of the Arm, Shoulder and Hand</measure>
    <time_frame>6 weeks and 3, 6 and 12 mfup</time_frame>
    <description>is a 30-item, self-report questionnaire designed to measure physical function and symptoms in people with any of several musculoskeletal disorders of the upper limb.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Elbow Trauma Requiring Operative Management</condition>
  <arm_group>
    <arm_group_label>drug</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The treatment arm will receive 21 days of Indomethacin and Pantoprazole (gastrointestinal protective agent). The patients will receive Indomethacin 25mg three times a day and Pantoprozole 40mg once a day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo group will receive microcrystalline cellulose powder tablets to be taken as a control. The placebo will be dosed at the same intervals and duration as the treatment arm in this study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Indomethacin and Pantoprazole</intervention_name>
    <arm_group_label>drug</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>microcrystalline cellulose powder tablets</intervention_name>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Terrible Triad

          -  Radial head fracture surgical treatment

          -  Monteggia and Trans-olecranon Fracture Dislocations

          -  Distal Biceps Tendon Injuries

          -  Distal Humerus Fractures

          -  Coronoid Fractures

          -  Capitellar-Trochlear fractures

          -  Olecranon Fractures

        Exclusion Criteria:

          -  Associated Traumatic Brain Injury

          -  Burn Injuries associated with elbow trauma

          -  History of Gastric Ulcers

          -  Documented allergies to any Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

          -  Severe Asthma

          -  Previous operative fixation to affected elbow

          -  Participation in other research study

          -  Inability to speak / understand English
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>George Athwal, MD</last_name>
    <phone>519-646-6100</phone>
    <phone_ext>66081</phone_ext>
    <email>&lt;gathwal@uwo.ca&gt;</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kate Kelly, MSc, MPH</last_name>
    <phone>519-646-6100</phone>
    <phone_ext>64640</phone_ext>
    <email>Kate.Kelly@sjhc.london.on.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>HULC, St Joseph's Health Care</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4V2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Athwal, MD</last_name>
      <phone>519-646-6100</phone>
      <email>gathwal@uwo.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.coa-aco.org/</url>
    <description>Canadian Orthopaedic Association</description>
  </link>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2012</study_first_submitted>
  <study_first_submitted_qc>December 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2012</study_first_posted>
  <last_update_submitted>March 22, 2017</last_update_submitted>
  <last_update_submitted_qc>March 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lawson Health Research Institute</investigator_affiliation>
    <investigator_full_name>George Athwal</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Elbow trauma,Heterotopic Ossification,Indomethacin, Prophylaxis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Ossification, Heterotopic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pantoprazole</mesh_term>
    <mesh_term>Indomethacin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

